iSOFT Wins new e-Prescribing Deal at Harrogate NHS Trust

iSOFTHarrogate and District NHS Foundation Trust is the latest NHS trust to place an order with iSOFT, a CSC company, for its e-prescribing and medicines administration (ePMA) solution to improve medicines management and reduce the risk of drug-related mistakes.

The move is part of the trust's commitment to ensuring safe and effective care at the 367-bed Harrogate District Hospital. The ePMA solution will integrate with the trust's existing IT infrastructure including PAS, laboratory and eDischarge systems to further promote the timely and accurate sharing of medicines related information within the trust and with GPs.

"We are dedicated to making the safety of our patients and the quality of care our highest priority," said Andrew Alldred, Harrogate's director of pharmacy. "With the proliferation of new drugs, many with similar sounding names, prescribing has become a hugely complex task that is fraught with risk. Paper-based medicines systems can no longer be relied on to meet the demanding needs of a modern and clinically complex hospital environment."

"With research suggesting that at least ten percent of medication orders contain errors, costing the NHS in excess of £500 million a year, there has never been a greater need for ePMA solutions to help improve the timeliness, appropriateness and accuracy of the prescribing and administration of medicines," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "Our solution has been shown to greatly reduce adverse medication errors and improve the efficiency of healthcare services."

Harrogate is the fourth NHS trust to become an early adopter of iSOFT's ePMA solution after Pennine Acute, Stockport and Leicester. "Harrogate is a welcome addition to the early adopter programme," Stevens said. "The trust has already achieved an impressive range of meaningful clinical engagement and we are looking forward to continuing our strategic relationship to deliver real benefits for the trust’s staff and its patients."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management underpinned by clinical and workflow based decision support provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

iSOFT ePMA is shown to halve adverse medication errors at hospitals in Australia and New Zealand. These errors can prolong a patient's stay, which in turn blocks hospital beds and increases costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...